Description

BSE lists two series of Commercial Paper issued by Nuvama Wealth and Investment Limited on private placement basis, aggregating 8,000 units of Rs. 5 lakh each, maturing in January 2026.

Summary

BSE has listed two series of Commercial Paper issued by Nuvama Wealth and Investment Limited on private placement basis, effective October 24, 2025. The instruments are rated CRISIL A1+ and ICRA A1+, with ICICI Bank Ltd acting as the Issuing and Paying Agent. Both series have a face value of Rs. 5,00,000 each and will be traded only in dematerialized form.

Key Points

  • Two series of Commercial Paper listed totaling 8,000 units (4,000 units each)
  • Face value: Rs. 5,00,000 per unit for both series
  • Total value: Rs. 400 crore (Rs. 200 crore per series)
  • Credit Rating: CRISIL A1+ and ICRA A1+ for both series
  • Trading permitted only in dematerialized form
  • Standard denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Market lot: 1 unit

Regulatory Changes

No regulatory changes introduced by this circular.

Compliance Requirements

  • Trading members must ensure transactions are conducted only in dematerialized form under the specified ISIN numbers
  • Trading must be in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members should adhere to the tick size of 1 paise for these securities

Important Dates

Series 1 (NWIL-22-1-26-CP):

  • Date of Allotment: October 23, 2025
  • Date of Redemption: January 22, 2026
  • Listing Effective: October 24, 2025
  • Scrip Code: 730431
  • ISIN: INE523L14AN6
  • Issue Price: Rs. 490,642

Series 2 (NWI-20-1-26-CP):

  • Date of Allotment: October 23, 2025
  • Date of Redemption: January 20, 2026
  • Listing Effective: October 24, 2025
  • Scrip Code: 730432
  • ISIN: INE523L14AO4
  • Issue Price: Rs. 490,844

Impact Assessment

This is a routine debt instrument listing with minimal market impact. The listing provides short-term funding options for Nuvama Wealth and Investment Limited through the debt market and offers investment opportunities for institutional investors seeking highly-rated short-term instruments (approximately 3-month tenure). The high credit ratings (A1+ from both CRISIL and ICRA) indicate low credit risk. There is no impact on equity markets or broader trading operations.

Impact Justification

Routine debt instrument listing with no impact on equity markets or broader market operations